Jurmedika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 601,608 | 641,709 | 521,912 | 912,344 | 830,589 | 853,792 | 933,696 | 946,179 |
| Profit before tax | 185,731 | 90,196 | 84,693 | 239,860 | 148,896 | 151,382 | 107,787 | 50,211 |
| Net profit | 157,841 | 76,645 | 71,989 | 203,838 | 126,786 | 128,587 | 92,771 | 42,597 |
| Equity | 63,342 | 139,981 | 113,147 | 224,632 | 131,418 | 192,358 | 269,364 | 311,961 |
| Liabilities | 110,186 | 42,181 | 44,252 | 99,954 | 51,404 | 125,557 | 480,066 | 465,918 |
| Non-current assets | 87,770 | 94,278 | 64,700 | 47,116 | 77,585 | 86,869 | 670,841 | 664,878 |
| Current assets | 85,033 | 87,234 | 92,562 | 277,288 | 104,993 | 230,812 | 78,117 | 112,223 |
| Total assets | 172,803 | 181,512 | 157,262 | 324,404 | 182,578 | 317,681 | 748,958 | 777,101 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 119,633 | 134,288 | 124,399 |
| Social insurance contributions | - | - | - | - | - | 99,410 | 109,209 | 123,230 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.7% | +6.7% | -18.7% | +74.8% | -9.0% | +2.8% | +9.4% | +1.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 91.3% | 42.2% | 45.8% | 62.8% | 69.4% | 40.5% | 12.4% | 5.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 249.2% | 54.8% | 63.6% | 90.7% | 96.5% | 66.8% | 34.4% | 13.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.2% | 11.9% | 13.8% | 22.3% | 15.3% | 15.1% | 9.9% | 4.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 30.9% | 14.1% | 16.2% | 26.3% | 17.9% | 17.7% | 11.5% | 5.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | 0.3 | 0.4 | 0.4 | 0.4 | 0.7 | 1.8 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,664 | 33,923 | 26,315 | 45,428 | 35,095 | 37,667 | 43,597 | 47,113 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jurmedika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-01 | 2026-01-11 | 122.18 |
| 2025-12-16 | 2025-12-30 | 122.18 |
| 2024-09-17 | 2024-09-26 | 34.46 |
| 2024-07-26 | 2024-08-07 | 3.60 |
| 2024-07-24 | 2024-07-25 | 158.09 |
| 2024-07-16 | 2024-07-23 | 154.49 |
| 2024-06-18 | 2024-06-30 | 276.94 |
| 2024-03-18 | 2024-03-27 | 58.08 |
| 2024-02-19 | 2024-03-13 | 79.64 |
| 2023-11-16 | 2023-11-23 | 292.46 |
| 2023-10-24 | 2023-11-12 | 11.71 |
| 2023-10-17 | 2023-10-23 | 11.35 |
| 2023-08-17 | 2023-08-23 | 154.33 |
| 2023-07-26 | 2023-08-10 | 109.55 |
| 2023-07-24 | 2023-07-25 | 109.57 |
| 2023-07-18 | 2023-07-23 | 109.11 |
| 2023-06-16 | 2023-07-09 | 61.26 |
| 2022-10-28 | 2022-11-13 | 6.92 |
| 2022-09-22 | 2022-09-27 | 657.73 |
| 2022-09-16 | 2022-09-21 | 1200.73 |
| 2022-08-23 | 2022-08-28 | 383.84 |
| 2022-07-27 | 2022-08-15 | 0.07 |
| 2022-07-25 | 2022-07-26 | 214.04 |
| 2022-07-19 | 2022-07-24 | 213.97 |
| 2022-07-18 | 2022-07-18 | 8713.97 |
| 2022-04-19 | 2022-05-04 | 12.26 |
| 2021-11-16 | 2021-11-24 | 76.95 |
Jurmedika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-18 | 2026-01-19 | 931.88 |
| 2026-01-17 | 2026-01-17 | 907.48 |
| 2026-01-16 | 2026-01-16 | 378.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jurmedika, UAB (code 302565599) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, the company generated revenue of €946.2K, slightly above €933.7K in 2024 and €853.8K in 2023. This indicates moderate top-line growth of 1.3% year on year and 10.8% over two years. Profitability weakened over the same period: net profit fell from €128.6K in 2023 to €92.8K in 2024 and €42.6K in 2025, while the net profit margin declined from 15.1% to 9.9% and then to 4.5%. At the end of 2025, total assets stood at €777.1K, supported by equity of €312.0K and liabilities of €465.9K. The balance sheet remained asset-intensive, with long-term assets of €664.9K and short-term assets of €112.2K. Key ratios for 2025 show ROE of 13.7%, ROA of 5.5%, debt-to-equity of 1.49, and asset turnover of 1.22x. Revenue per employee was €47.3K, and profit per employee was €2.1K.